140 related articles for article (PubMed ID: 12477713)
1. Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis.
Chen F; Chang R; Trivedi M; Capetanaki Y; Cryns VL
J Biol Chem; 2003 Feb; 278(9):6848-53. PubMed ID: 12477713
[TBL] [Abstract][Full Text] [Related]
2. Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation.
Chen MH; Hagemann TL; Quinlan RA; Messing A; Perng MD
ASN Neuro; 2013 Nov; 5(5):e00125. PubMed ID: 24102621
[TBL] [Abstract][Full Text] [Related]
3. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.
Byun Y; Chen F; Chang R; Trivedi M; Green KJ; Cryns VL
Cell Death Differ; 2001 May; 8(5):443-50. PubMed ID: 11423904
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
[TBL] [Abstract][Full Text] [Related]
5. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis.
Caulín C; Salvesen GS; Oshima RG
J Cell Biol; 1997 Sep; 138(6):1379-94. PubMed ID: 9298992
[TBL] [Abstract][Full Text] [Related]
6. Caspase proteolysis of the cohesin component RAD21 promotes apoptosis.
Chen F; Kamradt M; Mulcahy M; Byun Y; Xu H; McKay MJ; Cryns VL
J Biol Chem; 2002 May; 277(19):16775-81. PubMed ID: 11875078
[TBL] [Abstract][Full Text] [Related]
7. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
Weng C; Li Y; Xu D; Shi Y; Tang H
J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055
[TBL] [Abstract][Full Text] [Related]
8. On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria.
Schröder R; Goudeau B; Simon MC; Fischer D; Eggermann T; Clemen CS; Li Z; Reimann J; Xue Z; Rudnik-Schöneborn S; Zerres K; van der Ven PF; Fürst DO; Kunz WS; Vicart P
Hum Mol Genet; 2003 Mar; 12(6):657-69. PubMed ID: 12620971
[TBL] [Abstract][Full Text] [Related]
9. Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.
Panagopoulou P; Davos CH; Milner DJ; Varela E; Cameron J; Mann DL; Capetanaki Y
J Cell Biol; 2008 Jun; 181(5):761-75. PubMed ID: 18519735
[TBL] [Abstract][Full Text] [Related]
10. Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties.
Sharma S; Mücke N; Katus HA; Herrmann H; Bär H
J Mol Med (Berl); 2009 Dec; 87(12):1207-19. PubMed ID: 19763525
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis.
Chen F; Arseven OK; Cryns VL
J Biol Chem; 2004 Jun; 279(26):27542-8. PubMed ID: 15087450
[TBL] [Abstract][Full Text] [Related]
12. DEDD regulates degradation of intermediate filaments during apoptosis.
Lee JC; Schickling O; Stegh AH; Oshima RG; Dinsdale D; Cohen GM; Peter ME
J Cell Biol; 2002 Sep; 158(6):1051-66. PubMed ID: 12235123
[TBL] [Abstract][Full Text] [Related]
13. Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation.
Bär H; Kostareva A; Sjöberg G; Sejersen T; Katus HA; Herrmann H
Exp Cell Res; 2006 May; 312(9):1554-65. PubMed ID: 16519886
[TBL] [Abstract][Full Text] [Related]
14. Characterization of BAG3 cleavage during apoptosis of pancreatic cancer cells.
Wang HQ; Meng X; Gao YY; Liu BQ; Niu XF; Zhang HY; Du ZX
J Cell Physiol; 2010 Jul; 224(1):94-100. PubMed ID: 20232307
[TBL] [Abstract][Full Text] [Related]
15. Assembly of amino-terminally deleted desmin in vimentin-free cells.
Raats JM; Pieper FR; Vree Egberts WT; Verrijp KN; Ramaekers FC; Bloemendal H
J Cell Biol; 1990 Nov; 111(5 Pt 1):1971-85. PubMed ID: 1699950
[TBL] [Abstract][Full Text] [Related]
16. Muscle-specific expression of a dominant negative desmin mutant in transgenic mice.
Raats JM; Schaart G; Henderik JB; van der Kemp A; Dunia I; Benedetti EL; Pieper FR; Ramaekers FC; Bloemendal H
Eur J Cell Biol; 1996 Nov; 71(3):221-36. PubMed ID: 8929561
[TBL] [Abstract][Full Text] [Related]
17. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3).
Mandal D; Baudin-Creuza V; Bhattacharyya A; Pathak S; Delaunay J; Kundu M; Basu J
J Biol Chem; 2003 Dec; 278(52):52551-8. PubMed ID: 14570914
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy.
Sjöberg G; Jiang WQ; Ringertz NR; Lendahl U; Sejersen T
Exp Cell Res; 1994 Oct; 214(2):447-58. PubMed ID: 7925640
[TBL] [Abstract][Full Text] [Related]
19. Intermediate filament formation after transfection with modified hamster vimentin and desmin genes.
van den Heuvel RM; van Eys GJ; Ramaekers FC; Quax WJ; Vree Egberts WT; Schaart G; Cuypers HT; Bloemendal H
J Cell Sci; 1987 Nov; 88 ( Pt 4)():475-82. PubMed ID: 3332670
[TBL] [Abstract][Full Text] [Related]
20. Intermediate filaments control the intracellular distribution of caspases during apoptosis.
Dinsdale D; Lee JC; Dewson G; Cohen GM; Peter ME
Am J Pathol; 2004 Feb; 164(2):395-407. PubMed ID: 14742246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
